Skip to main content

Table 1 Baseline characteristics of subjects

From: A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression

Variables

n-CEA (n = 20)

DCEAS (n = 23)

P valueb

Female, n (%)

13 (65.0)

14 (60.9)

0.780

Age (y)a

66.5 ± 11.9

66.7 ± 13.6

0.969

Having previous stroke, n (%)

2 (10.0)

6 (26.1)

0.250

Post-stroke duration (m)a

10.2 ± 14.9

7.7 ± 11.6

0.547

Duration of PSD onset (m)a

4.9 ± 12.0

4.7 ± 10.7

0.953

Having antidepressant treatment at study entry, n (%)c

  

0.222

Fluoxetine (FLX)

14 (70.0)

15 (65.2)

 

Other antidepressant agentsd

5 (25.0)

3 (13.0)

 

Previous acupuncture experience, n (%)

14 (70.0)

13 (56.5)

0.362

Baseline MMSEa

23.5 ± 4.4

24.8 ± 4.8

0.354

Baseline HAMD-17a

28.1 ± 7.0

25.8 ± 5.0

0.225

Baseline CGI-Sa

4.8 ± 0.8

4.9 ± 0.5

0.580

Baseline BIa

37.8 ± 10.7

37.7 ± 11.3

0.975

  1. aContinuous data are expressed as mean ± SD.
  2. bStudent t test and Fisher Exact test were used to detect between-group differences of continuous and categorical data, respectively.
  3. cDuration of antidepressant treatment largely varied from 10 days to 2 years.
  4. dOther antidepressants were sertraline, citalopram, escitalopram, mirtazapine and flupentixol + melitracen.
  5. BI Barthel Index, CGI-S Clinical Global Impression-Severity, DCEAS Dense Cranial Electroacupuncture Stimulation, HAMD-17 17-item Hamilton Rating Scale for Depression, MMSE Mini-Mental Status Examination, n-CEA Non-invasive Cranial Electroacupuncture, PSD Post-stroke Depression.